{"id":"NCT03260894","sponsor":"Incyte Corporation","briefTitle":"Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)","officialTitle":"A Randomized, Open-Label, Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care (Sunitinib or Pazopanib) as First-Line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-679/ECHO-302)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-07","primaryCompletion":"2018-08-22","completion":"2025-06-04","firstPosted":"2017-08-24","resultsPosted":"2019-09-10","lastUpdate":"2025-07-29"},"enrollment":129,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Renal Cell Carcinoma (RCC)"],"interventions":[{"type":"DRUG","name":"Pembrolizumab","otherNames":["MK-3475"]},{"type":"DRUG","name":"Epacadostat","otherNames":["INCB024360"]},{"type":"DRUG","name":"Sunitinib","otherNames":["Sutent","SU11248"]},{"type":"DRUG","name":"Pazopanib","otherNames":["Votrient"]}],"arms":[{"label":"Pembrolizumab + Epacadostat","type":"EXPERIMENTAL"},{"label":"SoC (Sunitinib or Pazopanib)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat compared to sunitinib or pazopanib in participants with locally advanced/metastatic renal cell carcinoma (mRCC) with a clear cell component who have not received prior systemic therapy for their mRCC.","primaryOutcome":{"measure":"Objective Response Rate (ORR) of Pembrolizumab + Epacadostat Versus Standard of Care (SOC)","timeFrame":"Minimum up to 6 months","effectByArm":[{"arm":"Pembrolizumab + Epacadostat","deltaMin":1.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":140,"countries":["United States","Australia","Brazil","Canada","Chile","France","Germany","Hungary","Ireland","Italy","Japan","New Zealand","Norway","Russia","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["39054430"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":64},"commonTop":["Diarrhoea","Nausea","Hypertension","Fatigue","Anaemia"]}}